Risk assessment of engineered nanomaterials and nanotechnologies-A review

Toxicology

Volumn 269, Issue 2-3, 2010, Pages 92-104

  Savolainen, Kai ^a   Alenius, Harri ^a   Norppa, Hannu ^a   Pylkkänen, Lea ^a   Tuomi, Timo ^a   Kasper, Gerhard ^b  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Data gaps; Exposure; Health; Nanomaterials; Risk assessment; Testing strategy

Indexed keywords

CARBON NANOTUBE; IRIDIUM; NANOMATERIAL; SINGLE WALLED NANOTUBE; TITANIUM DIOXIDE;

CARCINOGENICITY; CHEMICAL COMPOSITION; GENOTOXICITY; HEALTH HAZARD; HUMAN; NANOANALYSIS; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; PHYSICAL CHEMISTRY; PNEUMONIA; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TOXICITY TESTING; WORK ENVIRONMENT;

AIR POLLUTANTS, OCCUPATIONAL; BLOOD CIRCULATION; EUROPEAN UNION; HUMANS; INHALATION EXPOSURE; NANOSTRUCTURES; NANOTECHNOLOGY; OCCUPATIONAL EXPOSURE; PNEUMONIA; RISK ASSESSMENT; TOXICITY TESTS;

EID: 77950145080     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.01.013     Document Type: Review

References (123)

1. Adlakha-Hutcheon G., Khaydarov R., Korenstein R., Varma R., Vaseashta A., Stamm H., Abdel-Mottaleb M. Nanomaterials, nanotechnology: applications, consumer products and benefits. Nanomaterials: Risks and Benefits 2009, 195-207. Springer, Dordrecht. I. Linkov, J. Steevens (Eds.).
2. Aitken, R.J., Creely, K.S., Tran, C.L., 2004. Nanoparticles: an occupational hygiene review. Health and Safety Executive Research Report 274. HSE Books, Norwich, UK.
3. Åkerman M.E., Chan W.C., Laakkonen P., Bhatia S.N., Ruoslahti E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:12617-12621.
4. Alenius H., Pakarinen J., Saris O., Andersson M.A., Leino M., Sirola K., Majuri M.-L., Niemela J., Matikainen S., Wolff H., von Hertzen L., Makela M., Haahtela T., Salkinoja-Salonen M. Contrasting immunological effects of two disparate dusts-preliminary observations. Int. Arch. Allergy Immunol. 2009, 149:81-90.
5. Baciu C.L., Becker J., Janshoff A., Sönnichsen C. Protein-membrane interaction probed by single plasmonic nanoparticles. Nano Lett. 2008, 8:1724-1728.
6. Balbus J.M., Maynard A.D., Colvin V.L., Castranova V., Daston G.P., Denison R.A., Dreher K.L., Goering P.L., Goldberg A.M., Kulinowski K.M., Monteiro-Riviere N.A., Oberdörster G., Omenn G.S., Pinkerton K.E., Ramos K.S., Rest K.M., Sass J.B., Silbergeld E.K., Wong B.A. Meeting report: hazard assessment for nanoparticles-report from an interdisciplinary workshop. Environ. Health Perspect. 2007, 115:1654-1659.
7. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., López-Quintela M.A. Penetration of metallic nanoparticles in human full-thickness skin. J. Invest. Dermatol. 2007, 127:1701-1712.
8. Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289:698-708.
9. Bergamaschi E. Occupational exposure to nanomaterials: present knowledge and future development. Nanotoxicolgy 2009, 3(3):194-201.
10. Bermudez E., Mangum J.B., Wong B.A., Asgharian B., Hext P.M., Warheit D.B., Everitt J.I. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol. Sci. 2004, 77:347-357.
11. Bhattacharya K., Davoren M., Boertz J., Schins R.P.F., Hoffmann E., Dopp E. Titanium dioxide nanoparticles induce oxidative stress and DNA adduct formation but not DNA breakage in human lung cells. Part. Fibre Toxicol. 2009, 6:17.
12. Bihari P., Vippola M., Schulte S., Praetner M., Khandoga A.G., Reichel C.A., Coester C., Tuomi T., Rehberg M., Krombach F. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part. Fibre Toxicol. 2008, 5:1-14.
13. Borm P.J.A., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdörster E. The potential risks of nanomaterials: a review carried out for ECETOC. Part. Fibre Toxicol. 2006, 3:11.
14. Cedervall T., Lynch I., Foy M., Berggård T., Donnelly S.C., Cagney G., Linse S., Dawson K.A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. Engl. 2007, 46:5754-5756.
15. Cedervall T., Lynch I., Lindman S., Berggård T., Thulin E., Nilsson H., Dawson K.A., Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl Acad. Sci. U. S. A. 2007, 104:2050-2055.
16. Chou C.-C., Hsiao H.-Y., Hong Q.-S., Chen C.-H., Peng Y.-W., Chen H.-W., Yang P.-C. Single-walled carbon nanotubes can induce pulmonary injury in mouse model. Nanolett. 2008, 8:437-445.
17. Cunningham M.J. Gene-cellular interactions of nanomaterials: genotoxicity to genomics. Nanotoxicology-Characterization, Dosing and Health Effects 2007, 173-196. Informa Healthcare, New York. N.A. Monteiro-Riviere, C.L. Tran (Eds.).
18. 2. Inhal. Toxicol. 2007, 18(Suppl. 1):202-212.
19. Di Sotto A., Chiaretti M., Carru G.A., Bellucci S., Mazzanti G. Multi-walled carbon nanotubes: lack of mutagenic activity in the bacterial reverse mutation assay. Toxicol. Lett. 2009, 184:192-197.
20. Dockery D.W., Pope C.A., Xu X., Spengler J.D., Ware J.H., Fay M.E., Ferris B.G., Speizer F.E. An association between air pollution and mortality in six U.S. Cities. N. Engl. J. Med. 1993, 329:1753-1759.
21. Donaldson K., Brown D., Clouter A., Duffin R., MacNee W., Renwick L., Stone V. The pulmonary toxicology of ultrafine particles. J. Aerosol. Med. 2002, 15:213-220.
22. Donaldson K., Tran L., Jimenez L., Duffin R., Newby D.E., Mills N., MacNee W., Stone V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part. Fibre Toxicol. 2005, 2:10.
23. Donaldson K., Aitken R., Tran L., Stone V., Duffin R., Forrest G., Alexander A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci. 2006, 92:5-22.
24. Donaldson K., Stone V., Seaton A., Tran L., Aitken R., Poland C. Re: Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J. Toxicol. Sci. 2008, 33:386-388. (author reply, p. 385).
25. Duffin R., Mills N.L., Donalndson K. Nanoparticles-a thoracic toxicology perspective. Yonsei Med. J. 2007, 48(4):561-572.
26. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., Potter R., Maynard A., Ito Y., Finkelstein J., Oberdörster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 2006, 114:1172-1178.
27. Elder A., Lynch I., Grieger K., Chan-Remillard S., Gatti A., Gnewuch H., Kenaway E., Korenstein R., Kuhlbusch T., Linker F., Matias S., Monteiro-Riviere N., Pinto V.R.S., Rudnitsky R., Savolainen K., Shvedova A. Human health risks of engineered nanomaterials: critical knowledge gaps in nanomaterials risk assessment. Nanomaterials: Risks and Benefits 2009, 3-29. Springer, Dordrecht. I. Linkov, J. Steevens (Eds.).
28. Falck G.C.M., Lindberg H.K., Suhonen S., Vippola M., Vanhala E., Catalán J., Savolainen K., Norppa H. Genotoxic effects of nanomaterials: induction of DNA damage and micronuclei by TiO2 in human bronchial epithelial cells. Hum. Exp. Toxicol. 2009, 28:339-352.
29. Feynman, R., 1959. There's plenty of room at the bottom: an invitation to enter a new field of physics. In: Gilbert, H.D. (Ed.), Miniaturization. Reinhold, New York [] Accessed November 27, 2007. http://www.its.caltech!edu/~feynman/plenty.html.
30. Folkmann J.K., Risom L., Jacobsen N.R., Wallin H., Loft S., Møller P. Oxidatively damaged DNA in rats exposed by oral gavage to C60 fullerenes and single-walled carbon nanotubes. Environ. Health Perspect. 2009, 117(5):703-708.
31. Gonzalez L., Lison D., Kirsch-Volders M. Genotoxicity of engineered nanomaterials: a critical review. Nanotoxicology 2008, 2:252-273.
32. Guzelian P.S., Victoroff M.S., Halmes C., James R.C. Clear path: towards an evidence-based toxicology (EBT). Hum. Exp. Toxicol. 2009, 28(2-3):71-79.
33. Heard D.E. Analytical Techniques for Atmospheric Measurement 2006, Blackwell, Oxford.
34. Hoet P.H., Brüske-Hohlfeld I., Salata O.V. Nanoparticles-known and unknown health risks. J. Nanobiotechnol. 2004, 2:12.
35. Hubbs A., Mercer R.R., Coad J.E., Battelli L.A., Willard P.A., Sriram K., Wolfarth M., Castranova V., Porter D. Persistent pulmonary inflammation, airway mucous metaplasia and migration of multiwalled carbon nanotubes from the lung after subchronic exposure, PS 2193. Toxicol. CD Off. J. Soc. Toxicol. 2009, 108(S-1):457.
36. Jacobsen N.R., Pojana G., White P., Møller P., Cohn C.A., Korsholm K.S., Vogel U., Marcomini A., Loft S., Wallin H. Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C(60) fullerenes in the FE1-Muta™Mouse lung epithelial cells. Environ. Mol. Mutag. 2008, 49:476-487.
37. Jacobsen N.R., Møller P., Jensen K.A., Vogel U., Ladefoged O., Loft S., Wallin H. Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice. Part. Fibre Toxicol. 2009, 6:2.
38. Jia G., Wang H., Yan L., Wang X., Pei R., Yan T., Zhao Y., Guo X. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ. Sci. Technol. 2005, 39:1378-1383.
39. Kane A.B., Hurt R.H. Nanotoxicology: the asbestos analogy revisited. Nat. Nanotechnol. 2008, 3(7):378-379.
40. Karlsson H.L., Cronholm P., Gustafsson J., Möller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21:1726-1732.
41. Karlsson H.L., Gustafsson J., Cronholm P., Möller L. Size-dependent toxicity of metal oxide particles-a comparison between nano- and micrometer size. Toxicol. Lett. 2009, 188(2):112-118.
42. Kearns P., Gonzalez M., Oki N., Lee K., Rodriguez F. The safety of nanotechnologies at the OECD. Nanomaterials: Risks and Benefits 2009, 351-358. Springer, Dordrecht. I. Linkov, J. Steevens (Eds.).
43. Khandoga A., Stampfl A., Takenaka S., Schulz H., Radykewicz R., Kreyling W., Krombach F. Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation 2004, 109:1320-1325.
44. Kisin E.R., Murray A.R., Keane M.J., Shi X.C., Schwegler-Berry D., Gorelik O., Arepalli S., Castranova V., Wallace W.E., Kagan V.E., Shvedova A.A. Single-walled carbon nanotubes: geno- and cytotoxic effects in lung fibroblast V79 cells. J. Toxicol. Environ. Health 2007, 70(24):2071-2079.
45. Kreyling W.G., Semmler M., Erbe F., Mayer P., Takenaka S., Schulz H., Oberdörster G., Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health A 2002, 65:1513-1530.
46. Kuempel E.D., Tran C.L., Castranova V., Bailer A.J. Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal. Toxicol. 2006, 18:717-724.
47. Kuhlbusch T.A., Fissan H. Particle characteristics in the reactor and pelletizing areas of carbon black production. J. Occup. Environ. Hyg. 2006, 3:558-567.
48. Kuhlbusch T.A.J., Fissan H., Asbach C. Nanotechnologies and Environmental risks: measurement technologies and strategies. Nanomaterials: Risks and Benefits 2009, 233-243. Springer, Dordrecht. I. Linkov, J. Steevens (Eds.).
49. Kuzma J. Moving forward responsibility: oversight for the nanotechnology-biology interface. Nanoparticles and Occupational Health 2007, 165-182. Springer, Dordrecht. A.D. Maynard, D.Y.H. Pui (Eds.).
50. Lam C.W., James J.T., McCluskey R., Arepalli J., Hunter R.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 2004, 77:126-134.
51. Lam C.W., James J.T., McCluskey R., Arepalli S., Hunter R.L. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 2006, 36:189-217.
52. Landsiedel R., Kapp M.D., Schulz M., Wiench K., Oesch F. Genotoxicity investigations on nanomaterials: Methods, preparation and characterization of test material, potential artifacts and limitations-many questions, some answers. Mutat. Res. 2009, 681:241-258.
53. Li J.G., Li W.X., Xu J.Y., Cai X.Q., Liu R.L., Li Y.J., Zhao Q.F., Li Q.N. Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation. Environ. Toxicol. 2007, 22:415-421.
54. Lindberg H.K., Falck G.C.M., Suhonen S., Vippola M., Vanhala E., Catalán J., Savolainen K., Norppa H. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicol. Lett. 2009, 186:166-173.
55. Linkov I., Satterstrom F.K., Steevens J., Ferguson E., Pleus R.C. Multi-criteria decision analysis and environmental risk assessment for nanomaterials. J. Nanoparticle Res. 2007, 9:543-554.
56. Linkov I., Satterstrom F.K. Nanomaterial risk assessment and risk management: review of regulatory frameworks. Real Time and Deliberative Decision Making: Application to Risk Assessment for Non-chemical Stressors 2008, 129-158. Springer, Amsterdam. I. Linkov, E. Ferguson, V.S. Magar (Eds.).
57. Long T.C., Saleh N., Tilton R.D., Lowry G.V., Veronesi B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ. Sci. Technol. 2006, 40:4346-4352.
58. Long T.C., Tajuba J., Sama P., Saleh N., Swartz C., Parker J., Hester S., Lowry G.V., Veronesi B. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ. Health Perspect. 2007, 115(11):1631-1637.
59. Lux Research Profiting from International Nanotechnolgy 2006, Lux Research Inc., New York.
60. Maynard A.D. Experimental determination of ultrafine TiO2 de-agglomeration in surrogate pulmonary surfactant-preliminary results. Ann. Occup. Hyg. 2002, 46(Suppl 1):197-202.
61. Ma-Hock, L., Treumann, S., Strauss, V., Brill, S., Luizi, F., Mertler, M., Wiench, K., Gamer, A., van Ravenzwaay, B., Landsiedel, R., 2009. Inhalation toxicity of multi-wall carbon nanotubes in rats exposed for 3 months. Toxicol. Sci. Advance Access published on July 7, 2009; doi:10.1093/toxsci/kfp146.
62. Maynard A.D., Baron P.A., Foley M., Shvedova A.A., Kisin E.R., Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J. Toxicol. Environ. Health A 2004, 67:87-107.
63. Maynard A.D., Aitken R.J., Butz T., Colvin V., Donaldson K., Oberdörster G., Philbert M.A., Ryan J., Seaton A., Stone V., Tinkle S.S., Tran L., Walker N.J., Warheit D.B. Safe handling of nanotechnology. Nature 2006, 444:267-269.
64. Maynard A.D., Aitken R.J. Assessing exposure to airborne nanomaterials: current abilities and future requirements. Nanotoxicology 2007, 1:26-41.
65. Maynard A.D., Pui D.Y.H. Nanotechnology and occupational health: new technologies-new challenges. Nanoparticles and Occupational Health 2007, 1-3. Springer, Dordrecht. A.D. Maynard, D.Y.H. Pui (Eds.).
66. Melkonyan M., Kozyrev S. The current state-of-the-art in the area of nanotechnology risk assessment in Russia. Nanomaterials: Risks and Benefits 2009, 309-315. Springer, Dordrecht. I. Linkov, J. Steevens (Eds.).
67. Monteiro-Riviere N.A., Inman A.O., Ryman-Rasmussen J.P. Dermal effects of nanomaterials. Nanotoxicology-Characterization, Dosing and Health Effects 2007, 317-338. Informa Healthcare, New York. N.A. Monteiro-Riviere, C.L. Tran (Eds.).
68. Nanotoxicology-Characterization, Dosing and Health Effects 2007, Informa Healthcare, New York. N.A. Monteiro-Riviere, C.L. Tran (Eds.).
69. Mouchet F., Landois P., Sarremejean E., Bernard G., Puech P., Pinelli E., Flahaut E., Gauthier L. Characterisation and in vivo ecotoxicity evaluation of double-wall carbon nanotubes in larvae of the amphibian Xenopus laevis. Aquat. Toxicol. 2008, 87(2):127-137.
70. Muller J., Decordier I., Hoet P.H., Lombaert N., Thomassen L., Huaux F., Lison D., Kirsch-Volders M. Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells. Carcinogenesis 2008, 29:427-433.
71. Muller J., Huaux F., Fonseca A., Nagy J.B., Moreau N., Delos M., Raymundo-Piñero E., Béguin F., Kirsch-Volders M., Fenoglio I., Fubini B., Lison D. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chem. Res. Toxicol. 2008, 21:1698-1705.
72. Muller, J., Delos, M., Panin, N., Rabolli, V., Huaux, F., Lison, D., 2009. Absence of carcinogenic response to multi-wall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol. Sci., ToxSci Advance Access published on May 8, 2009. doi:10.1093/toxsci/kfp100.
73. Nadagouda M.N., Varma R.S. Risk reduction via greener synthesis of nober metal nanostructures. Nanomaterials: Risks and Benefits 2009, 209-217. Springer, Dordrecht. I. Linkov, J. Steevens (Eds.).
74. Nasha D.G., Baera T., Johnston M.V. Aerosol mass spectrometry: an introductory review. Int. J. Mass Spectrom. 2006, 258:2-12.
75. Nasibulin A.G., Queipo P., Shandakov S.D., Brown D.P., Jiang H., Pikhitsa P.V., Tolochko O.V., Kauppinen E.I. Studies on mechanism of single-walled carbon nanotube formation. J. Nanosci. Nanotechnol. 2006, 6:1233-1246.
76. Nel A.E., Mädler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8(7):543-557.
77. Nel A., Xia T., Mädler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
78. Noble C.A., Prather K.A. Real-time single particle mass spectrometry: a historical review of a quarter century of the chemical analysis of aerosols. Mass Spectrom. Rev. 2000, 19:248-274.
79. Nurkiewicz T.R., Porter D.W., Barger M., Castranova V., Boegehold M.A. Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ. Health Perspect. 2004, 112:1299-1306.
80. Nurkiewicz T.R., Porter D.W., Barger M., Millecchia L., Rao K.M., Marvar P.J., Hubbs A.F., Castranova V., Boegehold M.A. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ. Health Perspect. 2006, 114:412-419.
81. Nurkiewicz T.R., Porter D.W., Hubbs A.F., Cumpston J.L., Chen B.T., Frazer D.G., Castranova V. Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part. Fibre Toxicol. 2008, 5:1.
82. Nurkiewicz T.R., Porter D.W., Hubbs A.F., Stone S., Chen B.T., Frazer D.G., Boegenhold M.A., Castranova V. Pulmonary nanoparicle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol. Sci. 2009, 110:191-203.
83. Oberdörster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 2004, 16:437-445.
84. Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2005, 2:8.
85. OECD Environment Directorate, 2008. OECD Quantitative Structure- Activity Relationships [(Q)SARs] Project. http://www.oecd.org/document/23/0,3343,en_2649_34373_33957015_1_1_1_1,00 .html.
86. Ostiguy, C., Soucy, B., Lapointe, G., Woods, C., Ménard, L., 2008. Health Effects of Nanoparticles. REPORT R-589. IRSST, Montréal.
87. Owen R., Crane M., Grieger K., Handy R., Linkov I., Depkedge M. Strategic approaches for the management of environmental risk uncertainties posed by nanomaterials. Nanomaterials: Risks and Benefits 2009, 369-384. Springer, Dordrecht. I. Linkov, J. Steevens (Eds.).
88. Pacurari M., Yin X.J., Ding M., Leonard S.S., Schwegler-berry D., Ducatman B.S., Chirila M., Endo M., Castranova V., Vallyathan V. Oxidative and molecular interactions of multi-wall carbon nanotubes (MWCNT) in normal and malignant human mesothelial cells. Nanotoxicology 2008, 2:155-170.
89. Peters T.M., Elzey S., Johnson R., Park H., Grassian V.H., Maher T., O'Shaughnessy P. Airborne monitoring to distinguish engineered nanomaterials from incidental particles for environmental health and safety. J. Occup. Environ. Hyg. 2009, 6:73-81.
90. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A.H., Seaton A., Stone V., Brown S., MacNee W., Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008, 3:423-428. (Epub 2008, 20 May).
91. Prather K.A., Hatch C.D., Grassian V.H. Analysis of atmospheric aerosols. Annu. Rev. Anal. Chem. 2008, 1:485-514.
92. Pylkkänen, L., Alenius, H., Tuomi, T., Savolainen, K., 2007. The effect of nanoparticles on the expression of mRNA and proteins of chemokines and cytokines in inflammatory cells in the lungs. In: Proceedings of the Sixth Princess Chulabhorn International Science Congress: November 25-29, 2007; Bangkok, Thailand, pp. 237-241.
93. Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinski T., Radomski M.W. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 2005, 146:882-893.
94. Raivio, T., Pessala, P., Hjelt, M., Mikkanen, P., Kahelin, H., 2008. Nanosafety in Finland-a summary report. Tekes Review 224/2008, Helsinki, Finland.
95. REACH, 2006. Regulation (EC) No 1907/2006 of the European parliament and of the council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), http://eur-lex.europa.eu/LexUriServ/LexUriServ.do%3Furi=oj%3Al%3A2006%3A 396%3A0001%3A0849%3Aen%3Apdf.
96. Rossi, E.M., Pylkkänen, L., Koivisto, A.J., Vippola, M., Jensen, K.A., Miettinen, M., Sirola, K., Nykäsenoja, H., Karisola, P., Stjernvall, T., Vanhala, E., Kiilunen, M., Pasanen, P., Mäkinen, M., Hämeri, K., Joutsensaari, J., Tuomi, T., Jokiniemi, J., Wolff, H., Savolainen, K., Matikainen, S., Alenius, H., 2009. Airway exposure to silica coated TiO2 nanoparticles induces pulmonary neutrophilia in mice. Toxicol. Sci., Oct 29. [Epub ahead of print]. doi:10.1093/toxsci/kfp254.
97. Roller M., Pott F., Kamino K., Althoff G.H., Bellmann B. Dose-response relationship of fibrous dusts in intraperitoneal studies. Environ. Health Perspect. 1997, 105(Suppl. 5):1253-1256.
98. Rothenbacher S., Messerer A., Kasper G. Fragmentation and bond strength of airborne diesel soot agglomerates. Part. Fibre Toxicol. 2008, 5:9. 10.1186/1743-8977.
99. The Royal Society, 2004. Nanoscience and nanotechnologies: opportunities and uncertainties. http://www.nanotec.org.uk/finalReport.htm.
100. Sakamoto Y., Nakae D., Fukumori N., Tayama K., Maekawa A., Imai K., Hirose A., Nishimura T., Ohashi N., Ogata A. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J. Toxicol. Sci. 2009, 34:65-76.
101. Scientific Committee on Consumer Products, SCCP, 2007. Opinion on safety of nanomaterials in cosmetic products. [] European Commission, Health & Consumer Protection DG. Brussels. http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_123.pd f.
102. Scientific Committee on Emerging and Newly-Identified Health Risks SCENIHR, 2007. Opinion on the appropriateness of the risk assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials. [] European Commission, Health & Consumer Protection DG. Brussels. http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_ 004c.pdf.
103. Schulte P.A., Trout D., Zumwalde R.D., Kuempel E., Geraci C.L., Castranova V., Mundt D.J., Mundt K.A., Halperin W.E. Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science. J. Occup. Environ. Med. 2008, 50:517-526.
104. Schulte P.A., Schubauer-Berigan M.K., Mayweather C., Geraci C.L., Zumwalde R., McKernan J.L. Issues in the development of epidemiologic studies of workers exposed to engineered nanoparticles. J. Occup. Environ. Med. 2009, 51:323-335.
105. Seipenbusch M., Binnig J., Heim M., Weber A.P., Kasper G. Aerosol catalysis: the influence of particle structure on the catalytic activity of Pt nanoparticle agglomerates. Helv. Chim. Act. 2001, 84:3686-3701.
106. Seipenbusch M., Binder A., Kasper G. Temporal evolution of nanoparticle aerosols in workplace exposure. Ann. Occup. Hyg. 2008, 52:707-716.
107. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung. Cell Mol. Physiol. 2005, 289:L698-708.
108. Shvedova A.A., Kisin E., Murray A.R., Johnson V.J., Gorelik O., Arepalli S., Hubbs A.F., Mercer R.R., Keohavong P., Sussman N., Jin J., Yin J., Stone S., Chen B.T., Deye G., Maynard A., Castranova V., Baron P.A., Kagan V.E. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 295:552-565.
109. Shvedova A.A., Kisin E.R., Porter D., Schulte P., Kagan V.E., Fadeel B., Castranova V. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus?. Pharmacol. Ther. 2009, 121(2):192-204.
110. Speit G. Appropriate in vitro test conditions for genotoxicity testing of fibers. Inhal. Toxicol. 2002, 14:79-90.
111. Takagi A., Hirose A., Nishimura T., Fukumori N., Ogata A., Ohashi N., Kitajima S., Kanno J. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J. Toxicol. Sci. 2008, 33:105-116.
112. Wake D., Mark D., Northage C. Ultrafine aerosols in the workplace. Ann. Occup. Hyg. 2002, 46(Suppl.1):235-238.
113. Wang J., Liu Y., Jiao F., Lao F., Li W., Gu Y., Li Y., Ge C., Zhou G., Li B., Zhao Y., Chai Z., Chen C. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology 2008, 254:82-90.
114. Vincent J.H. Aerosol Sampling-Science, Standards, Instrumentation and Applications 2007, Wiley & Sons, West Sussex, UK.
115. Warheit D.B., Hoke R.A., Finlay C., Donner E.M., Reed K.L., Sayes C.M. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol. Lett. 2007, 171:99-110.
116. Warheit D.B. Long-term inhalation toxicity studies with multiwalled carbon nanotubes: closing the gaps or initiating the debate?. Toxicol. Sci. 2009, 112(2):273-275.
117. Warheit D.B., Laurence B.R., Reed K.L., Roach D.H., Reynolds G.A., Webb T.R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 2004, 77(1):117-125.
118. Weber A.P., Seipenbusch M., Kasper G. Size effects in the catalytic activity of unsupported metallic nanoparticles. J. Nanoparticle Res. 2003, 5:293-298.
119. Wirnitzer U., Herbold B., Voetz M., Ragot J. Studies on the in vitro genotoxicity of baytubes, agglomerates of engineered multi-walled carbon-nanotubes (MWCNT). Toxicol. Lett. 2009, 186:160-165.
120. Woodrow Wilson International Centre for Scholars, http://www.nanotechproject.org/.
121. Yang H., Liu C., Yang D., Zhang H., Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 2009, 29:69-78.
122. Yoshida R., Kitamura D., Maenosono S. Mutagenicity of water-soluble ZnO nanoparticles in Ames test. J. Toxicol. Sci. 2009, 34:119-122.
123. Zhu H., Yang H., Owen M.R. Combined microarray analysis uncovers self-renewal related signaling in mouse embryonic stem cells. Syst. Synth. Biol. 2007, 1(4):171-181.